StockData

EON Resources vs Arcadia Biosciences

EONR and RKDA side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How EONR and RKDA compare

EON Resources is the larger company, worth 29 times as much as Arcadia Biosciences ($13.4M against $466K).

Arcadia Biosciences grew revenue faster over the last twelve months (−12.2% versus −24.6% for EON Resources).

EON Resources keeps more of each dollar of sales as profit, with a net margin of −74.1% compared with −235% at Arcadia Biosciences.

Arcadia Biosciences scores higher on the StockData Score (6 against 3 for EON Resources), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricEONRRKDA
Size and price
Market cap$13.4M$466K
Share price$0.240$0.194
Change, 1 year−47.5%−95.0%
Change, 5 years–−99.7%
Beta (5Y)–1.69
Employees68
StockData Score
Total score36 (better)
Valuation score3 (better)1
Growth score00
Performance score00
Health score05 (better)
Dividend score00
Valuation
P/S0.9×0.1× (better)
Fair value$0.359–
Margin of safety33.1%–
Growth
Revenue growth (TTM)−24.6%−12.2% (better)
Revenue growth, 5Y average–−9.6%
Profitability
Gross margin–34.6%
Operating margin−116%−80.1% (better)
Net margin−74.1% (better)−235%
Return on equity−65.0%–
Return on invested capital−24.5%–
Financial health
Interest coverage−9.3×–
Current ratio0.163.49 (better)
Altman Z-score−1.21 (better)−69.78
Piotroski F-score23 (better)
Dividends and buybacks
Buyback yield−11.0%–
Shareholder yield−11.0%0.00% (better)
Ownership
Held by institutions9.7%8.8%
Held by insiders11.7%1.4%
Insider net buying, 12 months$0–
Short interest, % of float5.9%4.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.